Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure.
Francesca AlbertonLaura GalliRiccardo LolattoCaterina CandelaNicola GianottiMatteo ChiurloMartina RanzenigoMartina StranoAlessia UgliettiAntonella CastagnaPublished in: Drug design, development and therapy (2024)
Most individuals in this study achieved VS within 12 months from the beginning of a DRVc-based regimen; therefore, this treatment represent a viable option for people who have experienced VF on other regimens.